Vincent Vince Ippolito

Mr Ippolito worked with Dermavant Sciences, a biopharmaceutical company focused on products for inflammatory skin diseases and dermatological conditions. Prior to this, he worked with Anacor Pharmaceuticals, where he was responsible for marketing and sales functions and the development of the Company's product portfolio. He was also involved in the company's acquisition by Pfizer for US$5.2 billion. Earlier in his career, he was involved in the launch of multiple dermatology products at Medicis Pharmaceutical Corporation. During his time there, he held several senior leadership responsibilities across dermatology, sales, and marketing. He also participated in the sale of Medicis to Valeant for US$2.6 billion in 2012 and subsequently worked within the aesthetics business. He began his career at Novartis Pharmaceuticals, where he worked for 17 years in roles covering dermatology, pediatric, and respiratory products.